Placebo Injections Reduced Penile Curvature
A meta-analysis found that men with Peyronie disease saw minor curvature improvements after receiving placebo treatments.
Updated on Sept. 28, 2026 in Men’s Health
Live Poll
Does evidence of a placebo effect make you less likely to trust minor medical procedures?
A meta-analysis published on August 24, 2026, found that patients with Peyronie disease experienced an average reduction of approximately 5 degrees in penile curvature following placebo-controlled injections. These findings suggest that the act of injection itself may contribute to outcomes traditionally attributed to pharmacological agents.
Why it matters
This research indicates that procedural factors like mechanical stimulation may influence plaque elasticity, which could alter how clinicians measure the true efficacy of new treatments. Recognizing this placebo effect is essential for future trials to accurately isolate the impact of specific drugs versus the injection process.
A meta-analysis of 7 trials (6 randomized, 1 nonrandomized) involving 382 participants found a pooled mean reduction of 5.1 degrees in penile curvature after placebo injection. The study followed patients for 4 to 36 weeks to measure curvature changes from a mean baseline of 40 degrees.
The players
J Sex Med
A peer-reviewed scientific journal that publishes research on sexual medicine and urological health.
The details
The observed reduction likely stems from procedural variables that occur during intralesional therapy. Mechanical stimulation of the hardened plaque and localized tissue injury from the needle may temporarily increase the elasticity of the curvature-inducing plaque. Because this modification occurs independently of active medication, future clinical evaluations must utilize rigorous placebo-adjusted models to determine real therapeutic efficacy.
Timeline
August 24, 2026: The meta-analysis was published in J Sex Med.
Health Landscape
This finding highlights that mechanical factors are a critical consideration when evaluating the efficacy of intralesional pharmacologic therapy trials for Peyronie disease. It suggests a need for more rigorous control groups in urological research to separate actual drug performance from procedural side effects.
If you are considering intralesional therapies for Peyronie disease, discuss the expected outcomes and the role of the injection procedure with your urologist. Understanding that procedural stimulation may play a role in results can help set realistic expectations for your treatment plan.
The takeaway
The act of injecting a treatment into the tissue may be as important as the medication itself in shifting plaque elasticity. If you are exploring treatment options for curvature, ask your physician how procedural variables are accounted for in clinical success rates.
Further reading
For more information on managing urological conditions, visit our Men’s Health section.
Source note: This article includes information reported by Renal and Urology News.
Live Poll
Does evidence of a placebo effect make you less likely to trust minor medical procedures?
